Skip to main content
SpringerLink
Log in

Personalised Medicine and Public Health

  • Chapter
  • First Online:
Book cover Personalized Medicine

Part of the book series: Europeanization and Globalization ((EAG,volume 2))

Abstract

The relationship between personalised medicine and public health can be observed from three different standpoints, offering a framework for deliberation on the individual vs. social, i.e. personal/private vs. public, as follows: personalised medicine in public health, personalised medicine vs. public health and personalised medicine and public health. Analysis brings us to the third concept as the most suitable framework for the place and role of personalised medicine within the entire health care system. Namely, personalised medicine has the potential to embrace a proactive, preemptive, participative and preventive approach to the health and well-being of all citizens. This calls for a new taxonomy of health and disease and a redefinition of health care, which now has to be understood more as a process than as a system. At the centre of this new paradigm is an individual who has to be empowered to manage one’s own health and disease. The health literacy initiative plays the key role in this inclusiveness. This potential of personalised approach to the entire health care can be highlighted through the concept of proactive P4 medicine (predictive, preventive, personalised and participatory), where public health initiatives become participatory health initiatives, based on the inclusiveness of participatory biocitizens, taking action in participatory health communities.

Professor Vladimir Mićović, M.D., Ph.D., Head of Teaching Institute of Public Health of Primorje-Gorski Kotar County, Rijeka, Croatia.

 Professor Iva Sorta Bilajac, M.D., Ph.D., Teaching Institute of Public Health of Primorje-Gorski Kotar County, Rijeka, Croatia.

 Professor Đulija Malatestinić M.D., Ph.D., Head of Department of Health, Primorje-Gorski Kotar County, Rijeka, Croatia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    See Sorta-Bilajac (2012).

  2. 2.

    See Hastings Center (1996), pp. S1–S27.

  3. 3.

    See Veatch (1996), pp. 579–585.

  4. 4.

    See Frković (2006).

  5. 5.

    See Pellegrino et al. (1990), pp. 175–180.

  6. 6.

    See U.S. Department of Health and Human Services, U.S. Food and Drug Administration (2013).

  7. 7.

    See Kass (2001), pp. 1176–1182.

  8. 8.

    See Dickenson (2013a).

  9. 9.

    Ibid.

  10. 10.

    Ibid., 8.

  11. 11.

    See Dickenson (2013b), pp. 26–27.

  12. 12.

    See Dickenson (2014).

  13. 13.

    Ibid., 11.

  14. 14.

    See Callahan (2002), pp. 169–176.

  15. 15.

    Ibid., 12.

  16. 16.

    Ibid., 11.

  17. 17.

    Ibid., 11.

  18. 18.

    See Potter (1970), pp. 127–153.

  19. 19.

    See Jonsen (1993), pp. S1–S4.

  20. 20.

    Ibid., 8.

  21. 21.

    See European Science Foundation (ESF) (2012).

  22. 22.

    Ibid.

  23. 23.

    See Simmons et al. (2012), pp. 85–91.

  24. 24.

    See Trusheim et al. (2007), pp. 287–293.

  25. 25.

    See Mirnezami et al. (2012), pp. 489–491.

  26. 26.

    See National Research Council Committee on a Framework for Developing a New Taxonomy of Disease (2012).

  27. 27.

    See Cesuroglu et al. (2012), pp. 115–119.

  28. 28.

    Ibid., 21.

  29. 29.

    Ibid., 21.

  30. 30.

    See Woolf (2008), pp. 3140–3148.

  31. 31.

    Ibid., 21.

  32. 32.

    Ibid., 21.

  33. 33.

    Ibid., 21.

  34. 34.

    Ibid., 21.

  35. 35.

    Ibid., 21.

  36. 36.

    Ibid., 21.

  37. 37.

    Ibid., 21.

  38. 38.

    See Nutbeam (2000), pp. 259–267.

  39. 39.

    See Simonds (1974), pp. 1–10.

  40. 40.

    See U.S. Department of Health and Human Services (2000).

  41. 41.

    See HLS-EU Consortium (2012).

  42. 42.

    See Zweifel et al. (1997).

  43. 43.

    See Dukić et al. (2013).

  44. 44.

    Ibid., 21.

  45. 45.

    In attempt to approach the above-mentioned European initiative, Primorsko-goranska County launched the Health Literacy Innitiative within the project “Healthy County” for the 2015–2018 period. One of the partners in this initiative is the Teaching Institute of Public Health of the Primorsko-goranska County.

  46. 46.

    Ibid., 21.

  47. 47.

    See Jakab (2011), pp. 130–132.

  48. 48.

    See Hood and Friend (2011), pp. 184–187.

  49. 49.

    See Weston and Hood (2004), pp. 179–196.

  50. 50.

    See Swan (2012), pp. 93–118.

  51. 51.

    Ibid., 21.

  52. 52.

    See WHO (1946).

References

  • Callahan D (2002) Ethics and public health: forging a strong relationship. Am J Public Health 2:169–176

    Article  Google Scholar 

  • Cesuroglu T, van Ommen B, Malats N et al (2012) Public health perspective: from personalized medicine to personal health. Pers Med 9(2):115–119

    Article  Google Scholar 

  • Dickenson DL (2013a) ME medicine vs. WE medicine: reclaiming technology for the common good. Columbia University Press, New York

    Google Scholar 

  • Dickenson DL (2013b) “Me“ medicine could undermine public health measures. New Scientist 2934:26–27. http://www.newscientist.com/article/mg21929340.200-me-medicine-could-undermine-public-health-measures.html#.U1Zr19gU-0F. Accessed 18 Feb 2014

    Google Scholar 

  • Dickenson DL (2014) In me we trust: public health, personalized medicine, and the common good. Hedgehog Rev 16(1), http://www.iasc-culture.org/THR/THR_article_2014_Spring_Dickenson.php. Accessed 28 Apr 2014

  • Dukić N, Arbula Blecich A, Cerović Lj (2013) Economic implications of insufficient health literacy. Paper presented at the 6th International Conference “The changing economic landscape: issues, implications and policy options”, Pula, Croatia, 30 May–01 June 2013

    Google Scholar 

  • European Science Foundation (ESF) (2012) Forward look: personalised medicine for the European Citizen. ESF, Strasbourg Cedex

    Google Scholar 

  • Frković A (2006) Bioetika u kliničkoj praksi (Bioethics in clinical practice). Pergamena, Zagreb

    Google Scholar 

  • Hastings Center (1996) The goals of medicine: setting new priorities. Hastings Cent Rep 26(6):S1–S27

    Article  Google Scholar 

  • HLS-EU Consortium (2012) Comparative report of health literacy in eight EU member states. European Health Literacy Survey HLS-EU. http://www.health-literacy.eu. Accessed 10 Feb 2014

  • Hood L, Friend SH (2011) Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 8(3):184–187

    Article  Google Scholar 

  • Jakab Z (2011) Embarking on developing the new European health policy—health 2020. Eur J Public Health 21(1):130–132

    Article  Google Scholar 

  • Jonsen AR (1993) The birth of bioethics. Hastings Cent Rep 23(6):S1–S4

    Article  Google Scholar 

  • Kass NE (2001) An ethics framework for public health. Am J Public Health 11:1176–1182

    Google Scholar 

  • Mirnezami R, Nicholson J, Darzi A (2012) Preparing for precision medicine. N Engl J Med 366(6):489–491

    Article  Google Scholar 

  • National Research Council Committee on a Framework for Developing a New Taxonomy of Disease (2012) Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. The National Academies Press, Washington DC

    Google Scholar 

  • Nutbeam D (2000) Health literacy as public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promot Int 15(3):259–267

    Article  Google Scholar 

  • Pellegrino ED, Siegler M, Singer PA (1990) Teaching clinical ethics. J Clin Ethics 1:175–180

    Google Scholar 

  • Potter VR (1970) Bioethics, the science for survival. Perspect Biol Med 14:127–153

    Article  Google Scholar 

  • Simmons LA, Dinan MA, Robinson TJ et al (2012) Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare. Pers Med 9(1):85–91

    Article  Google Scholar 

  • Simonds SK (1974) Health education as social policy. Health Educ Monogr 2(1):1–10

    Article  Google Scholar 

  • Sorta-Bilajac I (2012) Kliničke etičke konzultacije. Autorizirano predavanje (Clinical ethics consultation. Authorised lecture). University of Rijeka School of Medicine, Rijeka

    Google Scholar 

  • Swan M (2012) Health 2050: The realization of personalized medicine through crowdsourcing, the quantified self, and the participatory biocitizen. J Pers Med 2:93–118

    Article  Google Scholar 

  • Trusheim MR, Berndt ER, Douglas FL (2007) Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov 6(4):287–293

    Article  Google Scholar 

  • U.S. Department of Health and Human Services (2000) Healthy people 2010: understanding and improving health, 2nd edn. U.S. Government Printing Office, Washington, DC

    Google Scholar 

  • U.S. Department of Health and Human Services, U.S. Food and Drug Administration (2013) Paving the way for personalized medicine: FDA’s role in a new era of medical product development. http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/PersonalizedMedicine/UCM372421.pdf. Accessed 08 Mar 2014

  • Veatch RM (1996) Uloga bioetike u stvaranju postmoderne medicine i utjecaj postmoderne medicine na bioetiku (The role of bioethics in the creation of postmodern medicine, and the influence of postmodern medicine on bioethics). Društvena istraživanja 23–24:579–585

    Google Scholar 

  • Weston AD, Hood L (2004) Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res 3(2):179–196

    Article  Google Scholar 

  • WHO (1946) WHO definition of health. http://who.int/about/definition/en/print.html. Accessed 23 Feb 2014

  • Woolf SH (2008) The meaning of translational research and why it matters. JAMA 299(2):3140–3148

    Google Scholar 

  • Zweifel P, Breyer F, Kifmann M (1997) Health economics, 2nd edn. Springer, Heidelberg

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Teaching Institute of Public Health, Primorje - Gorski Kotar County, Rijeka, Croatia

    Vladimir Mićović M.D., Ph.D., Iva Sorta-Bilajac Turina M.D., Ph.D. & Đulija Malatestinić M.D., Ph.D.

  2. University of Rijeka School of Medicine, Rijeka, Croatia

    Vladimir Mićović M.D., Ph.D., Iva Sorta-Bilajac Turina M.D., Ph.D. & Đulija Malatestinić M.D., Ph.D.

  3. Department of Health, Primorje - Gorski Kotar County, Rijeka, Croatia

    Đulija Malatestinić M.D., Ph.D.

Authors
  1. Vladimir Mićović M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Iva Sorta-Bilajac Turina M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Đulija Malatestinić M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Iva Sorta-Bilajac Turina M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Jean Monnet Department of European Public Law, University of Rijeka, Rijeka, Croatia

    Nada Bodiroga-Vukobrat

  2. Croatian Academy of Sciences and Arts, Rijeka, Croatia

    Daniel Rukavina

  3. Department of Biotechnology, University of Rijeka , Rijeka, Croatia

    Krešimir Pavelić

  4. University of Applied Sciences, Hochschule für öffentliche Verwaltung und Finanzen Ludwigsburg, Ludwigsburg, Germany

    Gerald G. Sander

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Mićović, V., Turina, I.SB., Malatestinić, Đ. (2016). Personalised Medicine and Public Health. In: Bodiroga-Vukobrat, N., Rukavina, D., Pavelić, K., Sander, G. (eds) Personalized Medicine. Europeanization and Globalization, vol 2. Springer, Cham. https://doi.org/10.1007/978-3-319-39349-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-39349-0_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-39347-6

  • Online ISBN: 978-3-319-39349-0

  • eBook Packages: Law and CriminologyLaw and Criminology (R0)

Publish with us

Policies and ethics

Search

Navigation